APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation General Anesthesia Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Inhalation General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025180 pages

Choose your research edition.

Industry ResearchInhalation General Anesthesia Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation General Anesthesia Drugs Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Inhalation General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation General Anesthesia Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation General Anesthesia Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Inhalation General Anesthesia Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Inhalation General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalation General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Inhalation General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhalation General Anesthesia Drugs include AbbVie, Baxter, LAB UNKNOWN, Maruishi, Piramal, PT Novell Pharmaceutical, Viatris and Hengrui, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalation General Anesthesia Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalation General Anesthesia Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalation General Anesthesia Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalation General Anesthesia Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalation General Anesthesia Drugs Segment by Company

AbbVie

Baxter

LAB UNKNOWN

Maruishi

Piramal

PT Novell Pharmaceutical

Viatris

Hengrui

Inhalation General Anesthesia Drugs Segment by Type

Isoflurane

Sevoflurane

Other

Inhalation General Anesthesia Drugs Segment by Application

Hospital

Clinic

Other

Inhalation General Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation General Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalation General Anesthesia Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhalation General Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Inhalation General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Inhalation General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Inhalation General Anesthesia Drugs Industry Trends Table 2. Inhalation General Anesthesia Drugs Industry Drivers Table 3. Inhalation General Anesthesia Drugs Industry Opportunities and Challenges Table 4. Inhalation General Anesthesia Drugs Industry Restraints Table 5. Global Inhalation General Anesthesia Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Inhalation General Anesthesia Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Inhalation General Anesthesia Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Inhalation General Anesthesia Drugs Sales Market Share by Manufacturers Table 9. Global Inhalation General Anesthesia Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Inhalation General Anesthesia Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Inhalation General Anesthesia Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Inhalation General Anesthesia Drugs Manufacturers, Product Type & Application Table 13. Global Inhalation General Anesthesia Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalation General Anesthesia Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Isoflurane Table 17. Major Manufacturers of Sevoflurane Table 18. Major Manufacturers of Other Table 19. Global Inhalation General Anesthesia Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 21. Global Inhalation General Anesthesia Drugs Sales by Type (2027-2032) & (K Units) Table 22. Global Inhalation General Anesthesia Drugs Sales Market Share by Type (2021-2026) Table 23. Global Inhalation General Anesthesia Drugs Sales Market Share by Type (2027-2032) Table 24. Global Inhalation General Anesthesia Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Inhalation General Anesthesia Drugs Revenue by Type (2021-2026) & (K Units) Table 26. Global Inhalation General Anesthesia Drugs Revenue by Type (2027-2032) & (K Units) Table 27. Global Inhalation General Anesthesia Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Inhalation General Anesthesia Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Other Table 32. Global Inhalation General Anesthesia Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 34. Global Inhalation General Anesthesia Drugs Sales by Application (2027-2032) & (K Units) Table 35. Global Inhalation General Anesthesia Drugs Sales Market Share by Application (2021-2026) Table 36. Global Inhalation General Anesthesia Drugs Sales Market Share by Application (2027-2032) Table 37. Global Inhalation General Anesthesia Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Inhalation General Anesthesia Drugs Revenue by Application (2021-2026) & (K Units) Table 39. Global Inhalation General Anesthesia Drugs Revenue by Application (2027-2032) & (K Units) Table 40. Global Inhalation General Anesthesia Drugs Revenue Market Share by Application (2021-2026) Table 41. Global Inhalation General Anesthesia Drugs Revenue Market Share by Application (2027-2032) Table 42. Global Inhalation General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Inhalation General Anesthesia Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Inhalation General Anesthesia Drugs Sales Market Share by Region (2021-2026) Table 45. Global Inhalation General Anesthesia Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Inhalation General Anesthesia Drugs Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Inhalation General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 49. North America Inhalation General Anesthesia Drugs Sales by Country (2027-2032) & (K Units) Table 50. Europe Inhalation General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 52. Europe Inhalation General Anesthesia Drugs Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Inhalation General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Inhalation General Anesthesia Drugs Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Inhalation General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Inhalation General Anesthesia Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Inhalation General Anesthesia Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Inhalation General Anesthesia Drugs Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Inhalation General Anesthesia Drugs Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Inhalation General Anesthesia Drugs Revenue Market Share by Region (2021-2026) Table 63. Global Inhalation General Anesthesia Drugs Revenue Market Share by Region (2027-2032) Table 64. AbbVie Company Information Table 65. AbbVie Business Overview Table 66. AbbVie Inhalation General Anesthesia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. AbbVie Inhalation General Anesthesia Drugs Product Portfolio Table 68. AbbVie Recent Development Table 69. Baxter Company Information Table 70. Baxter Business Overview Table 71. Baxter Inhalation General Anesthesia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Baxter Inhalation General Anesthesia Drugs Product Portfolio Table 73. Baxter Recent Development Table 74. LAB UNKNOWN Company Information Table 75. LAB UNKNOWN Business Overview Table 76. LAB UNKNOWN Inhalation General Anesthesia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. LAB UNKNOWN Inhalation General Anesthesia Drugs Product Portfolio Table 78. LAB UNKNOWN Recent Development Table 79. Maruishi Company Information Table 80. Maruishi Business Overview Table 81. Maruishi Inhalation General Anesthesia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Maruishi Inhalation General Anesthesia Drugs Product Portfolio Table 83. Maruishi Recent Development Table 84. Piramal Company Information Table 85. Piramal Business Overview Table 86. Piramal Inhalation General Anesthesia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Piramal Inhalation General Anesthesia Drugs Product Portfolio Table 88. Piramal Recent Development Table 89. PT Novell Pharmaceutical Company Information Table 90. PT Novell Pharmaceutical Business Overview Table 91. PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Product Portfolio Table 93. PT Novell Pharmaceutical Recent Development Table 94. Viatris Company Information Table 95. Viatris Business Overview Table 96. Viatris Inhalation General Anesthesia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Viatris Inhalation General Anesthesia Drugs Product Portfolio Table 98. Viatris Recent Development Table 99. Hengrui Company Information Table 100. Hengrui Business Overview Table 101. Hengrui Inhalation General Anesthesia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Hengrui Inhalation General Anesthesia Drugs Product Portfolio Table 103. Hengrui Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Inhalation General Anesthesia Drugs Distributors List Table 107. Inhalation General Anesthesia Drugs Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Inhalation General Anesthesia Drugs Product Image Figure 2. Global Inhalation General Anesthesia Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation General Anesthesia Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhalation General Anesthesia Drugs Sales (2021-2032) & (K Units) Figure 5. Global Inhalation General Anesthesia Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Inhalation General Anesthesia Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Isoflurane Image Figure 9. Sevoflurane Image Figure 10. Other Image Figure 11. Global Inhalation General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Inhalation General Anesthesia Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Inhalation General Anesthesia Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Inhalation General Anesthesia Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Inhalation General Anesthesia Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Inhalation General Anesthesia Drugs Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Inhalation General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Inhalation General Anesthesia Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Inhalation General Anesthesia Drugs Sales Market Share by Application (2021-2032) Figure 23. Global Inhalation General Anesthesia Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Inhalation General Anesthesia Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Inhalation General Anesthesia Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Inhalation General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 28. U.S. Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Inhalation General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 33. Germany Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Inhalation General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 40. China Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Inhalation General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 48. Brazil Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Inhalation General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Inhalation General Anesthesia Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Inhalation General Anesthesia Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 59. North America Inhalation General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Europe Inhalation General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Inhalation General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Inhalation General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Inhalation General Anesthesia Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Inhalation General Anesthesia Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Isoflurane
  • Sevoflurane
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • AbbVie
  • Baxter
  • LAB UNKNOWN
  • Maruishi
  • Piramal
  • PT Novell Pharmaceutical
  • Viatris
  • Hengrui

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Inhalation General Anesthesia Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Inhalation General Anesthesia Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Inhalation General Anesthesia Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Inhalation General Anesthesia Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Inhalation General Anesthesia Drugs Market Dynamics
  1. 2.1 Inhalation General Anesthesia Drugs Industry Trends
  2. 2.2 Inhalation General Anesthesia Drugs Industry Drivers
  3. 2.3 Inhalation General Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 Inhalation General Anesthesia Drugs Industry Restraints
3 Inhalation General Anesthesia Drugs Market by Manufacturers
  1. 3.1 Global Inhalation General Anesthesia Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Inhalation General Anesthesia Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Inhalation General Anesthesia Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Inhalation General Anesthesia Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhalation General Anesthesia Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Inhalation General Anesthesia Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Inhalation General Anesthesia Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhalation General Anesthesia Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhalation General Anesthesia Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhalation General Anesthesia Drugs Tier 1, Tier 2, and Tier 3
4 Inhalation General Anesthesia Drugs Market by Type
  1. 4.1 Inhalation General Anesthesia Drugs Type Introduction
  2. 4.1.1 Isoflurane
  3. 4.1.2 Sevoflurane
  4. 4.1.3 Other
  5. 4.2 Global Inhalation General Anesthesia Drugs Sales by Type
  6. 4.2.1 Global Inhalation General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Inhalation General Anesthesia Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Inhalation General Anesthesia Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Inhalation General Anesthesia Drugs Revenue by Type
  10. 4.3.1 Global Inhalation General Anesthesia Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Inhalation General Anesthesia Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Inhalation General Anesthesia Drugs Revenue Market Share by Type (2021-2032)
5 Inhalation General Anesthesia Drugs Market by Application
  1. 5.1 Inhalation General Anesthesia Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Inhalation General Anesthesia Drugs Sales by Application
  6. 5.2.1 Global Inhalation General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhalation General Anesthesia Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Inhalation General Anesthesia Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Inhalation General Anesthesia Drugs Revenue by Application
  10. 5.3.1 Global Inhalation General Anesthesia Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Inhalation General Anesthesia Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Inhalation General Anesthesia Drugs Revenue Market Share by Application (2021-2032)
6 Global Inhalation General Anesthesia Drugs Sales by Region
  1. 6.1 Global Inhalation General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalation General Anesthesia Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalation General Anesthesia Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Inhalation General Anesthesia Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Inhalation General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Inhalation General Anesthesia Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Inhalation General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Inhalation General Anesthesia Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Inhalation General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Inhalation General Anesthesia Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Inhalation General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Inhalation General Anesthesia Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Inhalation General Anesthesia Drugs Revenue by Region
  1. 7.1 Global Inhalation General Anesthesia Drugs Revenue by Region
  2. 7.1.1 Global Inhalation General Anesthesia Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Inhalation General Anesthesia Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Inhalation General Anesthesia Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Inhalation General Anesthesia Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Inhalation General Anesthesia Drugs Revenue (2021-2032)
  8. 7.2.2 North America Inhalation General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Inhalation General Anesthesia Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Inhalation General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Inhalation General Anesthesia Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Inhalation General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Inhalation General Anesthesia Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Inhalation General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AbbVie
  2. 8.1.1 AbbVie Company Information
  3. 8.1.2 AbbVie Business Overview
  4. 8.1.3 AbbVie Inhalation General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AbbVie Inhalation General Anesthesia Drugs Product Portfolio
  6. 8.1.5 AbbVie Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Inhalation General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Inhalation General Anesthesia Drugs Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 LAB UNKNOWN
  14. 8.3.1 LAB UNKNOWN Company Information
  15. 8.3.2 LAB UNKNOWN Business Overview
  16. 8.3.3 LAB UNKNOWN Inhalation General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 LAB UNKNOWN Inhalation General Anesthesia Drugs Product Portfolio
  18. 8.3.5 LAB UNKNOWN Recent Developments
  19. 8.4 Maruishi
  20. 8.4.1 Maruishi Company Information
  21. 8.4.2 Maruishi Business Overview
  22. 8.4.3 Maruishi Inhalation General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Maruishi Inhalation General Anesthesia Drugs Product Portfolio
  24. 8.4.5 Maruishi Recent Developments
  25. 8.5 Piramal
  26. 8.5.1 Piramal Company Information
  27. 8.5.2 Piramal Business Overview
  28. 8.5.3 Piramal Inhalation General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Piramal Inhalation General Anesthesia Drugs Product Portfolio
  30. 8.5.5 Piramal Recent Developments
  31. 8.6 PT Novell Pharmaceutical
  32. 8.6.1 PT Novell Pharmaceutical Company Information
  33. 8.6.2 PT Novell Pharmaceutical Business Overview
  34. 8.6.3 PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Product Portfolio
  36. 8.6.5 PT Novell Pharmaceutical Recent Developments
  37. 8.7 Viatris
  38. 8.7.1 Viatris Company Information
  39. 8.7.2 Viatris Business Overview
  40. 8.7.3 Viatris Inhalation General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Viatris Inhalation General Anesthesia Drugs Product Portfolio
  42. 8.7.5 Viatris Recent Developments
  43. 8.8 Hengrui
  44. 8.8.1 Hengrui Company Information
  45. 8.8.2 Hengrui Business Overview
  46. 8.8.3 Hengrui Inhalation General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hengrui Inhalation General Anesthesia Drugs Product Portfolio
  48. 8.8.5 Hengrui Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalation General Anesthesia Drugs Value Chain Analysis
  2. 9.1.1 Inhalation General Anesthesia Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalation General Anesthesia Drugs Production Mode & Process
  6. 9.2 Inhalation General Anesthesia Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalation General Anesthesia Drugs Distributors
  9. 9.2.3 Inhalation General Anesthesia Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst